ASM International (ASM) Q4 2024 earnings summary

Executive summary

• Achieved eighth consecutive year of double-digit growth, with 2024 sales up 12% at constant currencies, outpacing the WFE market.

• Q4 2024 revenue reached €809 million, up 27% year-over-year at the upper end of guidance, driven by GAA and HBM demand.

• Maintained leadership in ALD and expanded Si Epi market presence, with strong innovation and ESG progress.

• Solid cash position of €927 million at year-end, no debt, and a proposed €3.00 dividend per share.

• Announced €150 million share buyback to be executed over 2025/2026.

Financial highlights

• Q4 2024 revenue: €809 million, up 27% year-over-year; full-year 2024 sales: €2.933 billion, up 12% at constant currencies.

• Adjusted gross margin for FY 2024: 50.5% (Q4: 50.3%), up from 49.3% in 2023.

• Adjusted operating margin for FY 2024: 28.0% (Q4: 28.1%), up from 20.6% in 2023.

• Free cash flow increased 23% to €548 million; cash and cash equivalents at year-end: €927 million.

• Spares and service sales grew 49% year-over-year in Q4 and 29% for the full year.

Outlook and guidance

• FY 2025 revenue guidance: €3.2–3.6 billion; Q1 2025 revenue expected at €810–850 million, with further increase in Q2.

• Gross margin expected to normalize to 46–50% in 2025 as China sales moderate.

• Net R&D to remain at the upper end of the target range, with 10–15% growth expected.

• SG&A to remain stable in absolute terms, declining as a percentage of sales.

• China revenue expected to decrease in 2025 due to new U.S. export controls, projected in the low-to-high 20s percentage of total revenue.